Dr. Marty Makary

"When introduced at the time of menopause and for menopausal symptoms, there is a significant reduction in the risk of developing Alzheimer's disease." Roberta Diaz Brinton, Ph.D.

Thrilled to welcome Dr. George Tidmarsh as the new director of the Center for Drug Evaluation and Research. And grateful for the tremendous service of Dr. Corrigan-Curay, who has graciously agreed to extend her retirement date to ensure a smooth transition.

.@DrMakaryFDA breaks down how the Trump Administration is shifting course—reforming SNAP, improving school meals, and investing in NIH research on root causes of disease, not just symptom management. From @NIH to @US_FDA, we’re focused on prevention, not just prescriptions.

You’re free to buy all the cupcakes and candy you want. But taxpayer-funded programs like SNAP should be used to purchase healthy food – not junk food and sugary drinks. It’s great to see @USDA working with states to make these common-sense changes.

Dr. Tidmarsh brings exceptional scientific, regulatory, and operational expertise to @US_FDA. His experience spans the full arc of drug development—from bench to bedside. I look forward to working with him to strengthen our drug review programs, foster innovation, and advance…

Food and Drug Administration (FDA) Commissioner @DrMakaryFDA discusses the agency's actions during his first 100 days in office & goals during his tenure Watch here: tinyurl.com/9peupa64

About 5% of pregnant women take an SSRI — even though one SSRI product has been associated with birth defects. We’ll be hosting an expert panel to discuss SSRIs during pregnancy on Monday, July 21 at 10 a.m. It's important that we set this issue straight. fda.gov/patients/fda-e…

.@PepsiCo just announced it will eliminate artificial colors and flavors from Lay’s and Tostitos by year’s end—and expand the use of avocado and olive oil in place of canola and soybean oil. I urge every other food company to follow their lead and join the movement to Make…

Over 10% of American women of childbearing age take SSRIs, with about half continuing use during pregnancy. However, questions remain about efficacy during pregnancy and potential risks to mother and child. Join our expert roundtable THIS MONDAY, July 21 at 10 am for a…

The FDA and USDA are working together on new, evidence-based dietary guidelines — and they're not going to demonize natural saturated fat while ignoring ultraprocessed foods.

When I got to the FDA, I was shocked to learn that we had been allowing Americans’ living cells to be shipped to labs in China for gene editing before being shipped back and infused into Americans – sometimes without the patients even knowing.

The potential benefits of hormone replacement therapy for women have been in the bucket of things that modern medicine has underappreciated, underrecognized, and underfunded. Women need to know the real data on this topic – not dogma.

No clinical trial has ever shown that hormone replacement therapy for perimenopausal women increases the likelihood of dying of breast cancer. While some women can’t take HRT, the vast majority of women going through perimenopause can have both short and long-term health…

ICYMI: Highlights from yesterday’s expert panel on menopause and HRT for women. “Women deserve policy that reflects the current evidence and not outdated risks.” @heatherhirschMD

As always, great to speak with @megynkelly! Especially enjoyed our discussion of the medical dogma surrounding hormone replacement therapy that has misled women for decades.

“Estrogen is the only well-established intervention to reduce the frequency of osteoporosis fracture in post-menopausal women, to the tune of 30-50%… yet only 4% of women in this country are currently enjoying its benefits.” @DrVondaWright

Approximately 5% of pregnant women take an SSRI for depression. But SSRI use during pregnancy has been linked in observational studies to birth defects, miscarriages, and neurological and behavioral challenges in childhood. On Monday, July 21 at 10 a.m. ET, we’ll be hosting an…

I'm grateful to everyone who joined @US_FDA’s expert panel today on HRT and menopause! We had a fantastic discussion that explored the latest evidence as well as the medical dogma that has persisted since the 2002 Women's Health Initiative study. You can find the full panel…

My mother was among the 50 million+ women who were denied the potential benefits of hormone replacement therapy. She later suffered multiple bone fractures – so I was struck when a NEJM randomized controlled trial found that HRT started within 10 years of the onset of menopause…

The 2002 Women’s Health Initiative study caused millions of women to avoid hormone replacement therapy for fear of breast cancer. Amazingly – despite the headlines – the study DID NOT show any statistically significant increase in breast cancer mortality due to HRT.